Nerve mapping technology improves surgery for compressed nerves

Nerve mapping technology allows surgeons to determine whether surgery has been effective for relieving pressure from compressed nerves, which often function poorly and cause sciatica or pain and weakness in muscles supplied by the nerve.

In a small study involving 42 patients at Henry Ford Hospital, lead author and Stephen Bartol, M.D., says that mechanomyography, or MMG, is effective with measuring and determining whether nerves are compressed.

MMG, which functions by detecting muscle movement and sending real-time alerts to surgeons, measures the performance of nerves during surgery, thereby reducing the risk of inadequate surgery and eliminating the need for additional surgery.

While encouraged by his findings, Dr. Bartol urged caution that more research is needed involving larger patient populations.

"Traditionally, when we operated on someone who has nerve decompression, we didn't know if we had done enough during the surgery at the time. It was basically wait and see after the patient recovered," Dr. Bartol says. "With the MMG tool we can differentiate between normal and compressed nerves, and gauge the severity of the compression."

The study is being presented Friday at the American Academy of Orthoapedic Surgeons' annual meeting in Chicago.

It is estimated that back pain will affect eight of 10 people in their lifetime, and one-quarter of U.S. adults report having lasting at least one day in the past three months.

With the rise in minimally , physicians are craving the need for an effective tool to monitor nerve function during surgery.

Conventionally, surgeons assess nerve decompression using direct visualization or a probe called a Woodson elevator, methods Dr. Bartol describes as "purely subjective" and prone to error. Another method , or EMG, which monitors the electrical response of muscle, is unreliable because electrical noise in the operating room makes it difficult to quantify nerve responses, Dr. Bartol says.

MMG, Dr. Bartol says, monitors the same physiological effects as EMG but uses smart mechanical sensors that are not susceptible to electrical interference. He says clear signals of can be detected at low electrical current thresholds.

In the study, researchers sought to test the electrical threshold of stimulation of 64 nerves in 41 patients by direct contact prior to and after decompression, during which a small portion of bone over the nerve root is removed, enabling the nerve root to heal without hindrance.

Stimulation started at 1mA electrical current and gradually increased until an MMG response was achieved.

The findings:

  • Prior to decompression, 89 percent of nerves had an elevated median threshold of 4.89mA.
  • After decompression, nerves had a median threshold of 2.08mA and 70 percent had normal threshold of 1mA.
  • After decompression, all 64 nerves had measurable increases in MMG response.
  • After decompression, 98 percent of nerves with abnormal pre-compression values had a drop in threshold greater than 1mA.

Dr. Bartol says these findings show that MMG technology "allows the surgeon to make better decisions in the operating room. Inadequate means patients will continue to experience pain after surgery. Better testing during surgery should translate to better outcomes."

Related Stories

Recommended for you

The impact of bacteria in our guts

Aug 22, 2014

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

Aug 22, 2014

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

Aug 22, 2014

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments